Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00198965 · ClinicalTrials.gov registry record · NA
Olestra Containing Foods and Weight Loss and Weight Maintenance
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 257
- Enrollment target
NCT00198965: Completed NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT00198965 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 257 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00198965, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 257 participants
- Enrollment target
Study Summary
This study will be conducted over three phases. Phase I will be a 16-week weight lass phase. Phase II will be a 52-week maintenance phase. Phase III will be a follow-up phase. We will test three diet regimens: 1) an olestra group who will receive a weight-reducing diet that includes olestra-containing products; 2) a triglyceride group who will receive the same weight-reducing diet but with foods made with triglyceride (regular fat); 3) a low-fat group will be instructed to consume a diet made of traditionally low-fat foods that ate available in grocery stores (no olestra foods). These groups will be re-randomized for the maintenance phase and again assigned to one of the three weight loss regimens described above: olestra, triglyceride, or low-fat. In the double-blinded experimental design, groups receiving olestra foods will not be informed of the nutrient contents of the foods or told what fat substitute is used in the preparation. (The consent form will state that a new fat-substitute may be used in the study foods.) During a "run-in" phase, olestra versus regular-fat food sensory and tolerance tests will be conducted.
Interventions
- BEHAVIORAL dietary education
- BEHAVIORAL dietary education and provided full fat snack foods
- BEHAVIORAL dietary education and provided fat free snack foods
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 1999-03 |
| Est. Completion | 2003-12 |
| Phase | NA |
What the finished NCT00198965 record still lists
NCT00198965 is an interventional study that assigns participants to a tested intervention. The registered 257 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 3 interventions - of which dietary education is the first listed.
NCT00198965 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00198965 about?
NCT00198965 is a clinical study titled "Olestra Containing Foods and Weight Loss and Weight Maintenance". This study will be conducted over three phases. Phase I will be a 16-week weight lass phase. Phase II will be a 52-week maintenance phase. Phase III will be a follow-up phase. We will test three diet regimens: 1) an olestra group who will receive a weight-reducing diet that includes olestra-containi...
What is the current status of trial NCT00198965?
This trial is currently completed. It is a NA study. The enrollment target is 257 participants. The study started on 1999-03. Estimated completion is 2003-12.
What interventions are being tested in trial NCT00198965?
The interventions under investigation include: dietary education (BEHAVIORAL), dietary education and provided full fat snack foods (BEHAVIORAL), dietary education and provided fat free snack foods (BEHAVIORAL).
Who is sponsoring clinical trial NCT00198965?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00198965's enrollment target sits among peer trials
257 403rd of 2000 higher than 1,597 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03618550 · 257 participants · Phase 2
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- NCT04674267 · 257 participants · NA
Resilience and Equity in Aging, Cancer, and Health (REACH)
- NCT06099288 · 257 participants · NA
Strong Families Start at Home/Familias Fuertes Comienzan en Casa
- NCT06207084 · 257 participants · NA
The Fit With Us Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia